What You Should Know: - Prenosis Inc., a precision diagnostics company transforming clinical diagnosis with artificial intelligence, announced today the expansion of an existing partnership with Roche Diagnostics that will total close to $6 million to improve and expedite the clinical recognition of sepsis. - Building upon the collaboration that the companies started together in 2020, Prenosis will significantly expand its core NOSIS™ dataset, and the two companies will work together
Read More
PreciseMDX Launches Digital Health Platform to Automate Diagnostic Testing Experience
What You Should Know: - PreciseMDX, the leading end-to-end digital health platform, introduces a cloud-based solution that automates and simplifies the diagnostic testing experience, empowering labs to deliver a transformative journey to providers and patients. PreciseMDX dramatically improves connectivity between clinical labs, providers, and patients during every step of the diagnostic testing process for any type of test. - Their first-of-its-kind platform enables labs of any size to
Read More
Accenture Invests in Virtual Diagnostic Testing Platform ixlayer
What You Should Know: - Accenture Ventures announced a strategic investment in ixlayer, a leader in healthcare IT-focused on providing technology-based solutions for diagnostic testing. Terms of the investment were not disclosed. - Aimed at making lab testing more efficient, the company’s platform lies at the nexus of doctors, researchers, patients and medical facilities, providing healthcare providers, payors and governments with the cloud-based IT infrastructure to scale products and
Read More
Ro Acquires At-Home Diagnostic Testing Company Kit – M&A
What You Should Know: - Healthcare technology company, Ro today announced the acquisition of Kit, an at-home diagnostics company that offers self-administered diagnostic tests, including finger prick blood assays, blood pressure tests, weight measurement tools, and more—all shipped directly to their door. Financial details of the acquisition were not disclosed. - The acquisition of Kit will serve as a critical piece to Ro’s vertically integrated platform, which already offers
Read More
PHINs: Addressing the Fundamental Flaws that Have Broken Healthcare
The fundamental problem with healthcare can be summed up in one sentence: We expect healthcare services that cater to our individual needs, yet the health care system operates under a one-size-fits-all, trial-and-error model. It is a model that results in missed diagnoses, protracted illnesses, and even premature death and wastes $935 billion annually. The financial toll of this outmoded approach pales in comparison to the human toll. More than 128,000 people in the U.S. die each year
Read More
Boston Scientific Acquires Remote Cardiac Monitoring Company Preventice Solutions for $1.2B
What You Should Know: - Boston Scientific announces an agreement to acquire Preventice Solutions, a leading developer of mobile health solutions and remote monitoring services that connect patients and caregivers for $1.2B. - The acquisition of external cardiac monitoring technologies and services providers will expand Boston Scientific’s rhythm management diagnostics portfolio and capabilities. Boston
Scientific today announced that it has acquired
Preventice Solutions, Inc.,
a
Read More
Mayo Clinic Launches On-Demand Diagnostic Testing Platform for COVID-19
What You Should Know: - Mayo Clinic and Safe Health Systems launch a new health and connected diagnostics platform to lower costs and streamline access to care. - The SAFE platform enables the rapid implementation of custom digital health applications, which combine digital provider services, artificial intelligence-based care automation, and remote point of care diagnostics. Mayo Clinic and
Safe Health Group, Inc. announced the formation of Safe Health Systems, Inc.,
a
Read More
Talis Awarded $25M NIH Contract for Point-of-Care COVID-19 Testing
What You Should Know: - Today, Talis Biomedical Corporation announced it has
been awarded a $25M contract from the National Institutes of Health (NIH) as
part of Phase 2 of its Rapid Acceleration of Diagnostics (RADx) initiative as
well as another $100 million in additional financing. - The new funding will be used to scale manufacturing for
the launch of the Talis One™ diagnostic platform that provides rapid and highly
accurate detection of COVID-19 at points-of-care in 30 minutes
Read More
FDA Approves Cue Health’s Point-of-Care COVID-19 Test Using Nasal Swabs
What You Should Know: - The Food and Drug Administration (FDA) has awarded Cue Health Emergency Use Authorization (EUA) for its rapid, portable, molecular point of care COVID-19 test. - The company recently raised $100M in Series C funding from Menlo Park-based Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation – JJDC, Inc., ACME Capital, and other investment firms. Cue Health Inc.
(“Cue”), a healthcare
technology company,
Read More
FDA Approves Everlywell’s COVID-19 Test Home Collection Kit Using Nasal Swabs
What You Should Know: - FDA approves Everlywell’s COVID-19 Test Home Collection Kit under the emergency use authorization (EUA) allows an individual to self-collect a nasal sample at home using Everlywell’s authorized kit. - The Everlywell home-collection kit is currently the only authorized COVID-19 at-home sample collection kit for use with multiple authorized COVID-19 diagnostic tests. The U.S. Food and Drug
Administration (FDA) has issued emergency use authorization (EUA) to
Read More
